Results 71 to 80 of about 19,614 (168)

Gonorrhea Management in High‐, Limited‐ and No‐Resource Settings: Implications in the Context of Antimicrobial Resistance

International Journal of Dermatology, Volume 65, Issue 3, Page 444-455, March 2026.
ABSTRACT Gonorrhea, a common sexually transmitted infection caused by Neisseria gonorrhoeae, represents an escalating global public health threat due to antimicrobial resistance. The current review explores diverse approaches around the globe to gonorrhea management across various settings, with a focus on diagnostic strategies, treatment practices ...
Andrei Tanasov, Maciej Pastuszczak, George‐Sorin Tiplica   +2 more
wiley   +1 more source

Pseudomonas aeruginosa Isolation from Urine Culture in Hospitalised Patients: Incidence of Complicated Urinary Tract Infections and Asymptomatic Bacteriurias and Impact on Treatment of the EUCAST 2020 Update

Antibiotics
Background. Urinary tract infections (UTIs) and asymptomatic bacteriurias (ABU) represent a large field of interest for antimicrobial stewardship programmes especially after 2020 EUCAST update in antimicrobial susceptibility testing interpretation and ...
Carlo Pallotto, Paolo Milani, Caterina Catalpi, Donatella Pietrella, Giuseppe Curcio, Filippo Allegrucci, Anna Gidari, Elisabetta Svizzeretto, Giovanni Genga, Andrea Tommasi, Antonella Mencacci, Daniela Francisci   +11 more
doaj   +1 more source

The Need for a Revision of Fluoroquinolone Breakpoints for Interpretation of Antimicrobial Susceptibility Testing of Feline Bacterial Isolates

Journal of Veterinary Pharmacology and Therapeutics, Volume 49, Issue 2, Page 131-140, March 2026.
ABSTRACT The fluoroquinolone antimicrobial agents, enrofloxacin and marbofloxacin, were approved in the United States for cats in 1990 and 2001, respectively. In 2023, revised breakpoints for testing isolates from dogs were published. These canine breakpoints are discordant with the current feline breakpoints.
Mark G. Papich, Lacie A. Gunnett, Marilyn N. Martinez   +2 more
wiley   +1 more source

Влияние расхождений критериев CLSI и EUCAST на интерпретацию чувствительности Enterobacteriaceae к карбапенемам

Антибиотики и Химиотерапия, 2021
Актуальность: Две  системы определения восприимчивости бактерий к антивомикробным препаратам CLSI и EUCAST рекомендованы для применения в глобальной системе эпидемиологического надзора за устойчивостью к противомикробным препаратам Всемирной Организации ...

doaj  

Die Entwicklung von EUCAST

, 2013
Bad Honnef-Symposium ...
openaire   +2 more sources

Time Kill Curve PD Modelling Experiments Are Affected by Trailing MIC Endpoints: Refinement of MIC Determination for S. pseudintermedius

Journal of Veterinary Pharmacology and Therapeutics, Volume 49, Issue 2, Page 220-227, March 2026.
ABSTRACT Trailing endpoints are a recognised challenge in broth microdilution MIC testing, particularly for bacteriostatic agents such as trimethoprim (TMP) and sulphonamides. In this study, we applied a pharmacodynamically guided refinement to determine the MIC of the combination against Staphylococcus pseudintermedius; we did not aim at redefining ...
Andrew Mead, Ludovic Pelligand
wiley   +1 more source

Neues von EUCAST und NAK

, 2014
Im Juni 2012 wurde das Nationale Antiinfektiva-Sensitivitätstestkomitee gegründet. Seine Aufgaben umfassen die Verbreitung und Implementierung der EUCAST-Methodik sowie der entsprechenden Grenzwerte. Gleichzeitig repräsentiert es die deutschen Interessen im Steering-Committee und im General[for full text, please go to the a.m. URL]
openaire   +1 more source

Clinical Outcomes of Intra‐Abdominal Candidiasis by Initial Antifungal Therapy

Mycoses, Volume 69, Issue 3, March 2026.
ABSTRACT Background Intra‐abdominal candidiasis (IAC) is a severe and heterogeneous infection associated with significant morbidity and mortality. Objectives To evaluate outcomes of IAC according to initial antifungal therapy and to identify predictors of persistent infection and 30‐day mortality.
M. Albanell‐Fernández, A. Vergara, F. Marco, S. Herrera, M. Tuset, A. Soriano, M. Bodro   +6 more
wiley   +1 more source

Prevalence Rates, Species Distribution and Antifungal Susceptibility of Rare Candida and Related Saccharomycotina Yeasts Causing Bloodstream Infections in 28 Medical Centres

Mycoses, Volume 69, Issue 3, March 2026.
ABSTRACT Background There is a lack of contemporary studies addressing the prevalence rates and antifungal susceptibility of bloodstream infections (BSI) caused by rare yeasts (RY) from the Saccharomycotina subphylum. Objectives This 16‐year multicentre study (2007–2023) aimed to assess the prevalence and antifungal susceptibility of rare yeasts ...
Carolina Palamin Buonafine, Alexander E. dos Santos, Larissa Molina Favarello, Regielly C. R. Cognialli, Valerio R. Aquino, Ana V. A. Mendes, Thais Guimarães, Teresa C. T. Sukiennik, Fabianne Carlesse, Paulo de Tarso O. E. Castro, Vania A. Vicente, Elaine C. Francisco, Arnaldo L. Colombo   +12 more
wiley   +1 more source

First Report of Fluconazole‐Resistant Candida parapsilosis Harbouring the G458S ERG11p Substitution in a Brazilian Hospital

Mycoses, Volume 69, Issue 3, March 2026.
ABSTRACT Background Fluconazole‐resistant Candida parapsilosis is a matter of concern. Objectives To investigate fluconazole resistance among Candida parapsilosis complex isolates from patients admitted to three Brazilian hospitals, and to characterise resistance mechanisms and clonal relatedness. Patients/Methods A total of 76 C.
Sarah Santos Gonçalves, Simone Bravim Maifrede, Eduardo Yäkel, Pedro Massaroni Peçanha, Francisco Ozório Bessa‐Neto, Rodrigo Cayô, Anderson Messias Rodrigues, Patricia Muñoz, Pilar Escribano, Jesús Guinea   +9 more
wiley   +1 more source